FLUIDIGM CORP
FLUIDIGM CORP
Aktie · US34385P1084 · LAB · A0RADJ (XNAS)
Übersicht Finanzkennzahlen
1,09 USD
1,40 % 0,01 USD
NASDAQ (XNAS) · Aktuelle Kurse und Charts bei MoneyPeak
09.06.2025 19:45

Aktuelle Kurse von FLUIDIGM CORP

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
LAB
USD
09.06.2025 19:45
1,09 USD
1,06 USD
+2,36 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
1,40 % 3,33 % -2,69 % -6,47 % -40,38 % -53,23 % -69,78 %

Firmenprofil zu FLUIDIGM CORP Aktie

Fluidigm Corporation creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, Advanta Dx SARS-CoV-2 RT-PCR assays, Advanta Dx COVID-19 EASE assays, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 systems; preparatory analytical instruments, which include C1 IFCs; and software solutions. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. Fluidigm Corporation has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Unternehmensdaten

Name FLUIDIGM CORP
Firma Standard BioTools Inc.
Symbol LAB
Website https://www.fluidigm.com
Heimatbörse XNAS NASDAQ
WKN A0RADJ
ISIN US34385P1084
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Diagnostics & Research
CEO Mr. Stephen Linthwaite
Marktkapitalisierung 294 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,6 T
Adresse 7000 Shoreline Ct Ste 100, 94080 South San Francisco
IPO Datum 2011-02-10

Kennungs-Wechsel

Datum Von Zu
06.04.2022 FLDM LAB

Ticker Symbole

Name Symbol
Frankfurt FLB.F
NASDAQ FLDM
NASDAQ LAB

Weitere Aktien

Investoren die FLUIDIGM CORP die halten, haben auch folgende Aktien im Depot:
ALPHABET INC - CLASS C
ALPHABET INC - CLASS C Aktie
AMGEN INC
AMGEN INC Aktie
AUTODESK INC
AUTODESK INC Aktie
BOEING CO
BOEING CO Aktie
CHARTER COMMUNICATIONS INC - CLASS A
CHARTER COMMUNICATIONS INC - CLASS A Aktie
CISCO SYSTEMS INC
CISCO SYSTEMS INC Aktie
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Aktie
DZ BANK      IS.A2402
DZ BANK IS.A2402 Anleihe
INTEL CORP
INTEL CORP Aktie
MICROSOFT CORP
MICROSOFT CORP Aktie
NEWMARK GROUP INC - CLASS A
NEWMARK GROUP INC - CLASS A Aktie
PHATHOM PHARMACEUTICALS INC
PHATHOM PHARMACEUTICALS INC Aktie
THE DUCKHPORTFOLIO INC
THE DUCKHPORTFOLIO INC Aktie
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025